drugset / Trial / NCT07126795
Magnesium Sulfate in Pediatric Burn Dressing Changes
RandomizedSingle-groupTriple-blindTreatment
Summary
Prospective feasibility trial utilizing adjuvant magnesium sulfate for analgesia/sedation during pediatric sedated burn dressing changes, which is ultimately hypothesized to decrease ketamine and/or sedative requirements.
Timeline
- Start
- 2027-12
- Primary completion
- 2030-12
- Completion
- 2031-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 50 mg/kg | Intravenous |
Indications
No indication recorded.